|
|
 |
|
Viewing report
|
|
 |
 |
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition)
ADIS, Jan 2001, Pages: 296
The Genesis Group examines the Competitive Strategies for the world's leading manufacturers of autoimmune/inflammatory therapeutics in this new report which evaluates, rates, and ranks the winners and losers in the US market.
This report provides an analysis of current and future clinical research and product development projects in leading worldwide markets.
Extensive primary and secondary resources were used in the analysis and assessment of this market and preparation of this study.
Customers who bought this item also bought
Competitive Strategies in Dermatology
Respiratory Competitive Strategies: Competitive Analysis, Profiles and Portfolio Strategies of the Top 10 Respiratory Therapeutic Manufacturers in the US (2001 Edition)
Competitive Strategies in Pain Management, 2001 Edition
Autoimmune Market Outlook to 2012
Cardiology, Competitive Strategies, 2002
Diabetes Competitive Strategies
Competitive Strategies in Cancer Medicine, 2000
Competitive Strategies in Antiviral Medicine, 2001 Edition
CNS - Competitive Analysis, Profiles and Portfolio Strategies of CNS Therapeutic Manufacturers in the US, 2002
2007 Annual Deep Research Report on China Steel Market
Commercial Insight: Autoimmune Overview - Market continues to prosper
Autoimmune Disease Therapeutics
|
 |
|
|